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H5N1 pathogenesis studies in mammalian models
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Abstract
H5N1 influenza viruses are capable of causing severe disease and death in humans, and represent 
a potential pandemic subtype should they acquire a transmissible phenotype. Due to the expanding 
host and geographic range of this virus subtype, there is an urgent need to better understand the 
contribution of both virus and host responses following H5N1 virus infection to prevent and 
control human disease. The use of mammalian models, notably the mouse and ferret, has enabled 
the detailed study of both complex virus–host interactions as well as the contribution of individual 
viral proteins and point mutations which influence virulence. In this review, we describe the 
behavior of H5N1 viruses which exhibit high and low virulence in numerous mammalian species, 
and highlight the contribution of inoculation route to virus pathogenicity. The involvement of host 
responses as studied in both inbred and outbred mammalian models is discussed. The roles of 
individual viral gene products and molecular determinants which modulate the severity of H5N1 
disease in vivo are presented. This research contributes not only to our understanding of influenza 
virus pathogenesis, but also identifies novel preventative and therapeutic targets to mitigate the 
disease burden caused by avian influenza viruses.
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1. Introduction
Avian influenza viruses represent a persistent threat to public health. Wild aquatic birds, the 
reservoir for all influenza A viruses, harbor numerous virus subtypes to which humans have 
little to no preexisting immunity. Among these, H5, H7, and H9 avian influenza viruses have 
been found to circulate in domestic poultry, causing human disease and further increasing 
the risk of human exposure to these subtypes (Abdel-Ghafar et al., 2008; Belser et al., 
2009a; Peiris et al., 1999). As previous pandemic viruses have derived from avian host 
origins, understanding the pathogenicity of avian influenza viruses in mammalian species is 
critical to predict the pandemic potential of these viruses (Garten et al., 2009). Should an 
avian virus to which humans lack neutralizing antibody acquire the ability to cause illness in 
humans and possess the capacity for sustained human-to-human transmission, a pandemic 
could result.
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Since 2003, there have been over 600 documented cases of human infection with H5N1 
viruses, with most cases among young, previously healthy individuals (WHO, 2013). Severe 
cases have been distinguished by high viral load and intense inflammatory responses, 
progressing to severe pneumonia, acute respiratory distress syndrome and death; the fatality 
rate is approximately 60% (Abdel-Ghafar et al., 2008; de Jong et al., 2006; WHO, 2013). 
While the majority of documented cases of H5N1 infection represent severe illnesses, milder 
cases have also been reported; based on limited seroepidemiologic studies, additional 
undocumented mild or asymptomatic cases have likely occurred (Abdel-Ghafar et al., 2008). 
Most cases of H5N1 human infection have occurred following exposure to H5N1 virus-
infected poultry, however selected reports of familial clusters suggest a host genetic 
component in susceptibility (Kandun et al., 2006; Olsen et al., 2005). Collectively, these 
epidemiologic studies support the existence of H5N1 viruses of varying virulence in 
humans, with an additional role for host factors in the resulting course of illness. There is an 
urgent need to study the contribution of both virus and host responses following H5N1 virus 
infection to improve our ability to both prevent and control human disease.
Mammalian models have become invaluable for the study of H5N1 virus pathogenicity. The 
intravenous pathogenicity index (IVPI), which classifies avian influenza viruses as high or 
low pathogenicity in 6-week-old chickens, does not reflect the pathogenesis of these viruses 
in mammals (WHO, 2002). Clinical and epidemiological data collected from human cases 
does not provide a biological or molecular basis of virus pathogenicity in humans. 
Furthermore, only the use of well-characterized laboratory models can provide the ability to 
study the contribution of individual viral genes and/or point mutations as well as complex 
virus–host interactions. While the mouse and ferret represent the mammalian models most 
typically used for the study of H5N1 virus pathogenesis, and whose use has enabled much of 
our understanding of viral pathogenesis discussed in this review, they are among several 
species which support influenza virus replication and are employed in the laboratory. As will 
be described below, each model possesses its own set of advantages and limitations, which 
include distribution patterns of cellular receptors, presentation of clinical signs and 
symptoms during acute infection, cost and size considerations, a well-characterized genome, 
and availability of species-specific reagents. The use of these models has provided a greater 
understanding of the pathogenicity of avian influenza viruses in mammals as well as the 
molecular determinants which confer a high virulence phenotype, information which is 
vitally needed in public health response to H5N1 virus infection in humans.
2. H5N1 viral pathogenesis in mice
2.1. Viral pathogenesis following intranasal inoculation
Despite several limitations, mice have traditionally been the most common mammalian 
model used for the study of influenza virus pathogenesis due to their small size, low cost, 
easy husbandry and well-characterized genetics. While avian influenza viruses typically 
replicate efficiently in mouse lungs without prior adaptation, the relative paucity of α(2-6)-
linked sialic acids (SA) in murine respiratory tissues limits the ability to study many human 
influenza viruses which possess this receptor binding preference (Ibricevic et al., 2006; van 
Riel et al., 2006). Furthermore, H5N1 virus attachment in the mouse is most abundant in 
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tracheal cells, becoming progressively weaker toward the alveoli, opposite to the pattern of 
virus attachment with this virus subtype in humans (van Riel et al., 2007). Unlike humans, 
mice do not run fevers or develop easy-to-measure respiratory clinical signs following 
influenza virus infection. However, mice display numerous physical signs of illness 
(including weight loss, ruffled fur, and lethargy) that can be used as measurable outcomes 
and markers of virulence depending on the strain used to infect. Furthermore, the temporal 
association between virus replication and symptom onset, lung pathology, and induction of 
innate immune responses in the mouse lead this model to be frequently used for studies of 
influenza virus pathogenesis (Conn et al., 1995; Hennet et al., 1992).
Like most avian influenza viruses, H5N1 subtype viruses are highly infectious in mice and 
typically replicate to high titer in murine lungs following intranasal (i.n.) inoculation (Gao et 
al., 1999; Gubareva et al., 1998; Lu et al., 1999; Maines et al., 2005). Depending on the 
strain, H5N1 viruses generally fall into either a high or low pathogenicity phenotype in this 
species (Gao et al., 1999; Katz et al., 2000; Maines et al., 2005). While maintaining a high 
degree of infectivity, viruses of low virulence cause mild to modest weight loss (generally 
<15% of pre-inoculation body weight), are typically restricted to replication in respiratory 
tract tissues, and usually clear by days 7–9 post-inoculation (p.i.) (Maines et al., 2005). In 
contrast, infection with highly virulent viruses leads to pronounced morbidity, systemic 
spread of virus, cytokine dys-regulation, severe tissue pathology, and death (Maines et al., 
2005). Infectious virus is frequently detected in the brains of mice infected with highly 
virulent H5N1 viruses, with elevated levels of numerous proinflammatory cytokines and 
chemokines also induced in this tissue (Park et al., 2002; Tanaka et al., 2003; Tumpey et al., 
2000). However, select H5N1 viruses can cause lethality in mice in the absence of 
extrapulmonary virus detection (Tumpey et al., 2002).
Numerous parameters contribute to the virulence of H5N1 viruses in the mouse model. 
H5N1 viral load in the lungs of mice has been associated with disease severity (Boon et al., 
2011; Hatta et al., 2010). Highly virulent viruses induce greater levels of apoptosis in the 
lung and spleen following infection and cause a significant reduction in the number of 
circulating lymphocytes in peripheral blood (Maines et al., 2005; Tumpey et al., 2000). 
Lymphocyte destruction and diminished expression of chemotactic factors can lead to 
reduced migration of immune cells to infected lung tissue, prolonging the viral infection and 
contributing to virus-induced pathology (Katz et al., 2000; Tumpey et al., 2000). 
Furthermore, exacerbated proinflammatory cytokine responses are frequently detected 
during severe H5N1 virus infection in mice, contributing to tissue pathology and fatal 
outcomes (Maines et al., 2008; Szretter et al., 2007). There is considerable variation among 
inbred mouse strains to H5N1 virus susceptibility and disease severity, indicating that host 
genetic components additionally contribute to H5N1 pathogenesis in mammals, as will be 
discussed in more detail in subsequent sections (Boon et al., 2011).
2.2. Viral pathogenesis following alternate inoculation routes
While intranasal administration of a liquid inoculum is the traditional method for assessment 
of influenza virus pathogenicity in mammalian species, it does not encapsulate all potential 
routes of exposure which can result in human disease (Fig. 1). Use of the mouse model to 
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evaluate alternate inoculation routes capable of causing a productive infection has allowed 
for a greater understanding of the capacity of H5N1 viruses to cause disease and death. 
Notably, conjunctivitis and other ocular complications following influenza virus infection in 
humans are most frequently associated with the H7 subtype, but have been documented 
rarely during H5N1 virus infection (Belser et al., 2009a). Furthermore, the presence of SA 
on the corneal surface and linkage of ocular and respiratory tract tissues by the nasolacrimal 
ducts identifies the ocular system as both a potential site of replication as well as a route of 
entry to establish a respiratory infection (Kumlin et al., 2008). Although H5N1 viruses do 
not demonstrate a particular tropism for this tissue, ocular inoculation (with or without prior 
corneal scarification) of mice with H5N1 viruses resulted in a systemic infection, with 
infectious virus recovered from the lungs, brain, and eye of mice p.i. (Belser et al., 2009b; 
Sun et al., 2009). Selected H5N1 viruses were capable of mounting a lethal infection by this 
route, albeit with a 2–3 delay in mortality compared with i.n. inoculation (Belser et al., 
2009b).
The detection of H5N1 virus in raw meat from land-based poultry has raised concerns 
regarding the ability of this virus subtype to cause disease following digestive exposure 
(Swayne, 2006; Tumpey et al., 2002). H5N1 subtype viruses shown to cause severe disease 
and death following i.n. inoculation in mice exhibited a range of pathogenicies following 
intragastric (i.g.) inoculation in this species (Lipatov et al., 2009). Select H5N1 viruses were 
capable of systemic spread and lethality, with infectious virus detected in the lungs, brain, 
and intestine following i.g. challenge. While the transmission of avian influenza viruses to 
humans via the consumption of contaminated poultry products is considered unlikely, 
evaluation of this inoculation route nonetheless provides a greater understanding of this 
property, especially given the detection of H5N1 viruses in poultry and egg products 
(Chmielewski and Swayne, 2011).
The mouse has been further employed to evaluate the ability of H5N1 viruses to cause 
disease following direct introduction in discrete organ systems. Systemic spread of virus was 
detected following intraperitoneal (i.p.) challenge with H5N1 virus, although infectious 
virus in the brain was not detected (Sun et al., 2009). Intravenous (i.v.) inoculation with 
H5N1 viruses resulted in a systemic and fatal infection of mice (Bright et al., 2003). H5N1 
viruses also caused fatal infections in the mouse following intracranial (i.c.) inoculation, 
with detection of systemic spread of virus beyond the inoculated tissue with some strains 
(Bright et al., 2003). Collectively, these studies demonstrate that H5N1 viruses are capable 
of causing severe disease and death following numerous routes of entry to the experimental 
host.
3. H5N1 viral pathogenesis in ferrets
3.1. H5N1 viruses of low virulence
The high susceptibility of ferrets (Mustela putorius furo) to influenza virus infection was 
identified shortly after first isolation of the virus (Shope, 1934). The ferret has proved to be 
an attractive mammalian model for the study of influenza virus pathogenesis as, unlike mice, 
this species emulates numerous clinical features associated with human disease, including 
sneezing, fever, and nasal discharge (Belser et al., 2011b). Furthermore, similarities between 
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ferret and human lung physiology allow for a greater extrapolation of experimental results to 
humans. Like humans, ferrets possess a predominance of α(2-6)-linked SA on upper airway 
epithelia, and avian and human influenza virus subtypes exhibit comparable patterns of virus 
attachment to respiratory tract tissues of both species (Maher and DeStefano, 2004; van Riel 
et al., 2006, 2007). As a result, ferrets support the efficient replication of human and avian 
influenza viruses following intranasal inoculation without prior adaptation.
Generally, ferret infection with human influenza viruses and low pathogenic avian influenza 
(LPAI) viruses of the H6, H7, and H9 subtypes presents as a mild, transient illness (Fig. 2) 
(Belser et al., 2007; Gillim-Ross et al., 2008; Smith and Sweet, 1988; Wan et al., 2008; 
Zitzow et al., 2002). Despite their classification as highly pathogenic avian influenza (HPAI) 
viruses, it is not atypical for H5N1 viruses to exhibit a similarly mild infection following i.n. 
inoculation in ferrets. Ferret infection with H5N1 viruses of low virulence is typically 
characterized by fever, mild to modest weight loss (<15% of pre-inoculation body weight), 
relatively mild lethargy and minimal clinical signs (Govorkova et al., 2005; Imai et al., 2010; 
Lu et al., 2003; Maines et al., 2005; Yen et al., 2007b). Lymphopenia in peripheral blood is 
transient, and neurological complications and death are rare (Maines et al., 2005). Ferrets 
return to pre-inoculation body weight and activity levels by 14 days p.i.
H5N1 viruses which exhibit low virulence in the ferret model replicate to moderate titer 
(peak mean titers generally ~105 EID50/ml) in the nasal cavities of ferrets through day 5 p.i. 
but typically clear infection at/around day 7 p.i., similar to human influenza viruses in this 
model (Maines et al., 2005). However, unlike H1N1 and H3N2 subtype viruses, H5N1 
viruses of low virulence in the ferret model are capable of efficient replication throughout 
the respiratory tract, with infectious virus frequently detected in the trachea and lungs of 
ferrets by day 3 p.i. (Maines et al., 2005). Despite the presence of viral antigen in the lung, 
macroscopic pulmonary discoloration in these ferrets is mild, with only localized 
inflammation present during acute infection. With the exception of virus detected in the 
olfactory bulb of the brain following i.n. inoculation with both avian and human influenza 
viruses (likely due to the proximity of high titers of infectious virus in the nasal turbinates), 
H5N1 viruses of low virulence in ferrets generally do not spread to extra-pulmonary tissues 
(Govorkova et al., 2005; Maines et al., 2005; Zitzow et al., 2002). Inflammation in the brain 
is not typically associated with infection with these viruses, and viral antigen is not 
consistently detected in this tissue (Maines et al., 2005).
3.2. Highly virulent H5N1 viruses
While not universal among all viruses in this subtype, HPAI H5N1 viruses have the capacity 
to cause severe and fatal disease in ferrets (Fig. 2). This severe disease is typically 
characterized by the presence of numerous clinical features, including fever, nasal discharge, 
lethargy, anorexia, diarrhea, and dyspnea, with pronounced weight loss (>15% of 
preinfection body weight) (Govorkova et al., 2005; Maines et al., 2005; Zitzow et al., 2002). 
Inoculation with highly virulent H5N1 viruses in the ferret often leads to a fatal infection; 
depending on the isolate, ferrets die during the acute phase of infection (typically days 5–7 
p.i.) in the absence of neurological dysfunction, or develop neurological symptoms 
(typically days 7–13 p.i.) necessitating euthanasia (Maines et al., 2005). It should be noted 
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that due to strain-specific differences and the outbred nature of ferrets, not all highly virulent 
H5N1 viruses which cause severe disease in ferrets result in 100% lethality of inoculated 
animals (Gustin et al., 2011b; Imai et al., 2010; Maines et al., 2005; Song et al., 2009).
Laboratory abnormalities in hematologic and serum chemistry parameters frequently 
observed in severe human cases of H5N1 virus infection are also detected in the ferret model 
(Abdel-Ghafar et al., 2008; Belser et al., 2011a; Yuen et al., 1998; Zitzow et al., 2002). 
Infection with highly virulent H5N1 viruses in ferrets can cause pronounced lymphocyte 
depletion in peripheral blood (as high as >75% reduction of lymphocytes compared with 
preinfection levels), in addition to leukopenia and thrombocytopenia (Belser et al., 2011a; 
Maines et al., 2005). Severe H5N1 disease in ferrets has further been shown to result in 
alterations to numerous blood chemistry parameters, indicative of multi-organ dysfunction 
(Belser et al., 2011a). Among these are atypical levels of alanine aminotransferase, amylase, 
and albumin, all of which have been reported among severe cases of H5N1 infection in 
humans (Kandun et al., 2006; Oner et al., 2006).
H5N1 viruses associated with severe disease in ferrets replicate to high titer in the nasal 
cavities of ferrets, with infectious virus persisting in the upper respiratory tract through day 
7 p.i. (Maines et al., 2005). Like H5N1 viruses of low virulence in this model, highly 
virulent H5N1 viruses replicate efficiently throughout the respiratory tract, but are detected 
at higher titer than less virulent viruses. The pattern of H5N1 virus attachment in ferret 
respiratory tract tissues closely mirrors that of humans, with greatest attachment in the 
alveoli and bronchioles (van Riel et al., 2007). However, infection with highly virulent 
H5N1 viruses results in severe macroscopic pathology and diffuse interstitial inflammation 
in pulmonary tissues, with more severe lesions present in the alveoli and bronchioles 
compared with the trachea and bronchi (Maines et al., 2005; van den Brand et al., 2010). 
Bronchopneumonia and acute bronchiolitis are detected as early as day 1 p.i. in H5N1 virus-
infected ferrets (Zitzow et al., 2002). Systemic spread of virus is common, with infectious 
virus detected in peripheral blood, spleen, liver, and intestine, among other organs 
(Govorkova et al., 2005; Maines et al., 2005).
Detection of virus in cerebrospinal fluid and development of acute encephalitis in isolated 
cases of severe H5N1 infection in humans indicates a role for neurologic involvement in 
H5N1 pathogenesis (Abdel-Ghafar et al., 2008; de Jong et al., 2005). Infectious virus and 
viral antigen are detected in the olfactory bulb and brain of ferrets infected with highly 
virulent H5N1 viruses, with neurons representing the major cell type infected in the central 
nervous system (Maines et al., 2005; Peng et al., 2012; Rowe et al., 2003). Viral load in the 
ferret brain has been shown to correlate with the severity of meningoencephalitis; high viral 
titers and inflammatory lesions in the brain can be detected by days 3–4 p.i., with widely 
distributed lesions present by days 5–6 p.i. (Peng et al., 2012). While the precise route of 
virus entry to the brain has yet to be elucidated, the olfactory system is a likely source of 
virus for brain invasion in ferrets infected with highly virulent H5N1 viruses, with entry via 
cranial nerve pathways or the brain vasculature also possible following disruption of the 
blood–brain barrier (Peng et al., 2012; Shinya et al., 2011a; Yamada et al., 2012).
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3.3. H5N1 viral pathogenesis following alternate inoculation routes
As ferrets share a greater number of clinical signs and symptoms with humans following 
influenza virus infection compared with mice, use of the ferret model has provided 
additional insight in elucidating the role of inoculation volume and route on virus 
pathogenicity. While the studies discussed above represent i.n. inoculation using a liquid 
virus suspension, modulation of the volume used during i.n. inoculation of ferrets can result 
in divergent disease profiles (Fig. 1). Compared with the 1 ml volume of inoculum which is 
frequently used during i.n. inoculation, a reduction in volume to 500 l or even 100 l can limit 
the respiratory tract tissues exposed to virus during the initial inoculation (Belser et al., 
2012; Bodewes et al., 2011). These studies demonstrate that the appropriate choice of 
inoculation method can greatly influence the resulting disease in ferrets.
While i.n. inoculation using a liquid virus suspension is the standard method for virus 
inoculation in ferrets, it does not accurately model the inhalation of small (<5 m) particles 
suspended in the air which represents a more natural route of virus transmission between 
humans. Furthermore, standard i.n. inoculation may result in the animal swallowing a 
portion of the inoculum, diverting the inoculum away from the respiratory tract. Recent 
advances in the generation and characterization of aerosolized virus particles in the 
laboratory have allowed for the establishment of aerosol methods of inoculation in the ferret 
to more closely model natural influenza virus infections in this model (Gustin et al., 2011a). 
Inoculation of ferrets by inhalation of aerosolized H5N1 virus resulted in a lethal infection, 
with systemic spread of virus detected p.i. (Gustin et al., 2011a; Lednicky et al., 2010). 
However, aerosol inoculation resulted in more gradual progress of disease compared with 
i.n. delivery, likely attributable to differences in virus dissemination (Gustin et al., 2011a).
Use of the ferret model has demonstrated the capacity of H5N1 viruses to cause severe 
disease in the absence of standard i.n./inhalation inoculation. Similar to studies performed in 
mice, H5N1 viruses are capable of maintaining a lethal phenotype following ocular 
inoculation in ferrets (Belser et al., 2009b, 2012). While there is a 2–3 day delay in onset of 
morbidity and mortality following ocular inoculation compared with i.n. administration of 
virus, comparable viral titers were detected in both respiratory tract and extrapulmonary 
tissues at time of death. In contrast to the mouse model, i.g. challenge with H5N1 virus in a 
liquid medium in ferrets did not result in a productive infection, likely due to inactivation of 
virus in the stomach before reaching the intestines (Lipatov et al., 2009). However, 
consumption of H5N1 virus-infected chicken tissues by ferrets lead to either mild 
respiratory disease (likely initiated in pharyngeal tissues in contact with virus-infected meat 
during consumption) or systemic disease (representing virus spread from the alimentary tract 
via the intestinal lymphatic system resulting in subsequent systemic circulation), depending 
on the virus strain used (Lipatov et al., 2009; Shinya et al., 2011b). This work highlights the 
ability of H5N1 viruses to cause varying disease profiles depending on the site of initial 
virus infection, and underscores the importance of choosing the appropriate method of 
inoculation when establishing an experimental design in the laboratory.
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4. H5N1 viral pathogenesis in other mammalian models
While the mouse and ferret represent the mammalian models most frequently employed in 
the laboratory to study H5N1 virus pathogenicity, many other species have also been 
examined. This work has allowed for a greater understanding of the potential for H5N1 
viruses to cause disease in a range of non-human hosts as well as providing for an 
assessment of the susceptibility of several mammalian species which are routinely handled 
as domestic animals or which pose a potential occupational hazard for individuals in close 
contact with these species.
The guinea pig has emerged as an alternate small mammalian model for the study of 
influenza viruses, notably with regard to the evaluation of virus transmissibility and the 
contribution of environmental factors on this property (Lowen et al., 2007). However, guinea 
pigs lack many of the clinical signs of infection seen in humans following influenza virus 
infection, and H5N1 viruses generally do not maintain a virulent phenotype in this species 
despite detection of infectious virus throughout the respiratory tract and the detection of 
bronchointerstitial pneumonia p.i. (Gao et al., 2009; Kwon et al., 2009; Steel et al., 2009a; 
Van Hoeven et al., 2009). While H5N1 viruses do not transmit efficiently from infected to 
naïve animals in the ferret model, guinea pigs inoculated with H5N1 viruses were capable of 
virus transmission when placed in direct contact with naïve animals (Gao et al., 2009; Steel 
et al., 2009a). Similar to studies in the ferret, i.g. inoculation of guinea pigs with H5N1 virus 
suspended in a liquid inoculum did not result in a productive infection (Kwon et al., 2009; 
Lipatov et al., 2009).
Non-human primates offer the advantage of a higher order species, but are only infrequently 
used in studies of H5N1 viral pathogenesis due to practical and ethical constraints. 
Cynomolgus macaques inoculated with H5N1 virus presented with numerous clinical signs 
of disease p.i., including coughing, fever, anorexia, and lethargy, leading to severe 
respiratory illness (Rimmelzwaan et al., 2001). Infectious virus was detected throughout the 
respiratory tract of these animals, as supported by the observation of severe necrotizing 
bronchointerstitial pneumonia, but virus was not isolated from the cerebellum or cerebrum 
in multiple studies (Kuiken et al., 2003; Rimmelzwaan et al., 2001; Ruat et al., 2008). 
Similar results highlighting the efficient replication of H5N1 virus in the lower respiratory 
tract in the absence of extrapulmonary virus detection were observed in rhesus macaques 
(Chen et al., 2009; Fan et al., 2009b). H5N1 virus replication in the upper respiratory tract of 
non-human primates in the absence of severe disease has also been reported, indicating 
strain-specific differences in virus pathogenicity in this species; similar to the guinea pig 
model discussed above, H5N1 viruses are typically nonlethal in non-human primates (Itoh et 
al., 2008; Van Hoeven et al., 2009). These studies have proven valuable in assessing vaccine 
efficacy to mitigate viral replication and pulmonary damage following H5N1 viral challenge, 
but studies of viral pathogenesis remain limited in comparison to more widely available 
models (Fan et al., 2009b; Itoh et al., 2008; Ruat et al., 2008). However, with high 
physiologic similarity with humans, the non-human primate model has been utilized for 
studies of system biology and the evaluation of host responses following H5N1 virus 
infection and nonlethal viral pneumonia, as will be discussed in the subsequent section 
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(Baskin et al., 2009; Cilloniz et al., 2009; Li et al., 2011b; McDermott et al., 2011; Shinya et 
al., 2012a; Tolnay et al., 2010).
Companion animals are not frequently used in laboratory settings to study influenza virus 
pathogenesis, but the potential for infection of dogs and cats with H5N1 virus (most likely 
following consumption of virus-infected poultry carcasses) and the resulting potential for 
viral adaptation or subsequent transmission to humans warrants closer study of H5N1 virus 
infection in these species (Harder and Vahlenkamp, 2010). Despite the emergence of H3N8 
canine influenza viruses in 2004, it is generally believed that species barriers restrict the 
permissiveness of dogs to influenza virus infection (Crawford et al., 2005; Harder and 
Vahlenkamp, 2010). Following the isolation of an H5N1 virus which caused a fatal infection 
of a dog in Thailand, this species was more closely examined for the ability to support H5N1 
virus infection, with strain-specific results (Songserm et al., 2006). Infectious virus was 
detected in respiratory samples collected from beagles inoculated with H5N1 virus but 
animals were generally asymptomatic aside from a transient rise in body temperature in two 
studies (Giese et al., 2008; Maas et al., 2007). However, severe disease following H5N1 
virus inoculation was detected in a separate study, with infected beagles presenting with 
fever, anorexia, diarrhea; infectious virus was recovered from respiratory tract samples only 
(Chen et al., 2010b). The detection of infectious virus recovered from both upper and lower 
respiratory tract samples was in accordance with patterns of virus attachment demonstrating 
that H5N1 virus binds to α(2-3) linked SA distributed throughout the upper and lower 
respiratory tract of dogs (Chen et al., 2010b; Maas et al., 2007).
While felids are not generally considered susceptible to influenza virus infection, reports of 
lethal H5N1 disease in domestic cats, tigers, and leopards have demonstrated the capacity 
for these species to succumb to HPAI virus infection (Kuiken et al., 2006). Cats inoculated 
with H5N1 virus by the i.n. or i.g. route presented with clinical signs of illness (including 
fever, lethargy, and dyspnea) with detection of infectious virus in respiratory and intestinal 
tissues (Giese et al., 2008; Kuiken et al., 2004; Vahlenkamp et al., 2010). Extapulmonary 
spread to numerous organ systems, including the brain, has also been reported in this species 
(Rimmelzwaan et al., 2006). The pattern of H5N1 virus attachment to cells of the lower 
respiratory tract in cats closely mirrors that observed in humans; in contrast, seasonal 
influenza viruses did not bind well to respiratory tract tissues in this species (van Riel et al., 
2007). These studies collectively demonstrate the extraordinary nature of H5N1 viruses to 
cause disease by multiple exposure routes in species not generally considered susceptible to 
influenza virus infection.
Other mammals are infrequently evaluated for their permissiveness to H5N1 virus infection. 
Golden Syrian hamsters have been used to model seasonal influenza virus infection but have 
only rarely been used in H5N1 pathogenesis studies, despite the ability of H5N1 viruses to 
spread systemically in this species following either i.n. or i.g. inoculation (Shinya et al., 
2011b). New Zealand White rabbits have been used to evaluate toxicity and protective 
immune responses to H5N1 influenza vaccination, but are rarely used for pathogenesis 
studies (Heldens et al., 2010; Zhu et al., 2011). However, rabbits were inoculated i.n. 
following the isolation of H5N1 virus in wild pikas (a closely related species) in China; 
infected rabbits shed virus from the upper respiratory tract and presented with fever p.i. but 
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the virus was otherwise not pathogenic in this species (Zhou et al., 2009). To determine the 
susceptibility of cattle to H5N1 virus infection, calves were inoculated by the i.n. route with 
H5N1 virus, resulting in asymptomatic virus shedding and seroconversion (Kalthoff et al., 
2008). These studies demonstrate the ability to use mammalian models not typically 
employed for studies of influenza virulence to nonetheless address if viruses that arise from 
serological or other surveillance activities pose a threat to mammalian health.
5. Contribution of host responses to H5N1 pathogenesis
5.1. Host cytokine responses in inbred mammalian models
The presentation of symptoms associated with the acute respiratory infection caused by 
influenza virus infection generally correlates with the onset and magnitude of host innate 
immune responses (Hayden et al., 1998). During uncomplicated influenza virus infection, 
the production of proinflammatory cytokines and chemokines in respiratory tract tissues, 
notably the early-phase cytokines such as type 1 interferons (IFN) and tumor necrosis factor 
(TNF) alpha, recruit numerous cell types to the site of infection, limit virus spread, and 
contribute to the induction of effective adaptive immune responses (Julkunen et al., 2001). 
However, during severe H5N1 virus infection in humans, cytokine dysregulation (or 
“cytokine storm”) leading to elevated levels of serum cytokines and chemokines has been 
reported in tandem with viremia and extra-pulmonary virus dissemination (de Jong et al., 
2006; Peiris et al., 2004). This exacerbated proinflammatory response is believed to 
contribute to the pathogenesis of H5N1 disease by leading to increased damage to host 
tissues, acute respiratory distress syndrome, and multiple organ dysfunction (Bhatia and 
Moochhala, 2004; Peiris et al., 2004; To et al., 2001). The contribution of individual 
cytokines and chemokines to H5N1 virus pathogenesis has been frequently studied with the 
use of animal models, including transgenic mice deficient in individual cytokines, ferrets 
which display numerous clinical signs of illness which correlate with inflammatory cytokine 
production, and macaques which possess the greatest physiologic similarity to humans.
Numerous cytokines and chemokines are expressed in the lungs of mice following infection 
with virulent H5N1 viruses, including the acute phase cytokines IL-1, IL-6, and TNF, 
macrophage inflammatory protein 1 alpha (MIP-1), monocyte chemotactic protein (MCP-1), 
and others (Szretter et al., 2007; Tumpey et al., 2000). Production of these cytokines elicits a 
rapid recruitment of macrophages and neutrophils into the lungs, contributing to subsequent 
acute lung inflammation in H5N1 virus-infected mice (Perrone et al., 2008). Due to 
overlapping functions, identification of individual roles of these cytokines has been achieved 
via the use of transgenic mice. Mice deficient in IL-1 receptor (IL-1R), IL-17, or IFNα/β 
receptor exhibited greater morbidity and mortality following H5N1 virus inoculation 
compared with wild-type controls, suggesting that these cytokines play a role in effective 
virus clearance and controlling systemic spread of virus (Szretter et al., 2007, 2009; Wang et 
al., 2011). Mice lacking TNFα or TNF receptors succumbed to H5N1 virus infection, with 
only modest reductions in morbidity observed in TNF receptor (TNFR) 1 deficient mice 
prior to death (Salomon et al., 2007a; Szretter et al., 2007). However, triple mutant mice 
deficient in three signaling receptors (TNFR1, TNFR2, and IL-1R) exhibited reduced 
morbidity, mortality, diminished cytokine production in the lungs, and decreased cellular 
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infiltrates in the lungs following H5N1 virus infection compared with wild-type mice 
(Perrone et al., 2010). Interestingly, mice deficient in IL-6, MIP-1, and CC chemokine 
ligand 2 (CCL2) showed no distinct phenotype compared with wild-type control mice 
following H5N1 virus inoculation (Salomon et al., 2007a; Szretter et al., 2007). Collectively, 
these studies highlight the redundancy of the host innate immune response, but nonetheless 
identify particular cytokines and pathways which serve critical roles in modulating H5N1 
viral pathogenesis in this model.
As excessive cytokine production has been implicated in H5N1 disease pathogenesis, several 
studies have examined if suppression of cytokines could mitigate disease severity. Treatment 
of H5N1 virus-inoculated mice with the natural murine glucocorticoid cortiocosterone 
resulted in modest reductions in morbidity but did not protect mice from death; furthermore, 
treatment with the glycocorticoid dexamethasone had no beneficial effect (Salomon et al., 
2007a; Xu et al., 2009). Mice deficient in NF-κB p50 exhibited reductions in 
hypercytokinemia following H5N1 infection but exhibited no difference in viral load or 
mortality compared with wild-type mice, suggesting that inhibition of local cytokine 
responses in the lung is not sufficient to alleviate H5N1 virus-mediated pathogenesis 
(Droebner et al., 2008). These studies are in agreement with microarray analyses which 
postulate that H5N1 viral pathogenesis is mediated primarily at the level of viral replication 
and not local cytokine responses (Cilloniz et al., 2010). Engagement of the IFN response 
prior to virus infection has also been purported to represent a viable therapeutic therapy to 
control influenza virus infection. Pretreatment of murine lung cells in vitro with IFNα/β 
resulted in a significant reduction in H5N1 viral replication, with comparable reductions in 
viral load observed in H5N1 virus-infected guinea pigs treated with exogenous IFNα 
(Szretter et al., 2009; Van Hoeven et al., 2009). Similarly, induction of Th1 responses and 
IFNγ in mice (either mediated by exposure to a Th1-inducing parasite or chitin 
microparticles, or via administration of exogenous IFNγ) resulted in decreased mortality 
following H5N1 virus challenge compared with untreated controls (Ichinohe et al., 2007; 
O’Brien et al., 2011b). These studies illustrate the important role of exploiting host innate 
antiviral responses to control influenza virus infection, and support the development of 
compounds which elicit or enhance this response in humans.
5.2. Host cytokine responses in outbred mammalian models
Outbred mammalian models used in the study of influenza virus pathogenesis, notably the 
ferret and macaque, provide a greater understanding of the complex responses following 
H5N1 virus infection and their role during human infection. While a general lack of ferret-
specific immunological reagents has limited our ability to use this model to examine 
induction of innate immune responses following influenza virus infection, analysis of 
genomic sequences in H5N1 virus-infected ferrets has nonetheless allowed for a greater 
understanding of host responses as they pertain to influenza virus pathogenicity and 
transmissibility. These studies have revealed a strong correlation between sites of virus 
replication and induction of local inflammatory mediators (Maines et al., 2012). Infection of 
ferrets with HPAI H5N1 viruses, which replicate efficiently in the lower respiratory tract, 
leads to higher levels of numerous cytokines and chemokines (including TNFα, IL-6, IL-8, 
IFNα/β, IFNγ, and CXCL9-11) in the lungs compared with ferrets infected with seasonal 
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and 2009 H1N1 viruses (Cameron et al., 2008; Maines et al., 2012). Correspondingly, ferrets 
infected with transmissible human viruses possessed higher levels of numerous 
inflammatory mediators in the nasal turbinates compared with H5N1 viruses which do not 
transmit efficiently in this model (Maines et al., 2012). Treatment of H5N1 virus-infected 
ferrets with a CXCR3 antagonist (resulting in a blockade of CXCL10 signaling) resulted in 
reduced morbidity and delayed mortality compared with untreated ferrets, further 
underscoring the role of host factors in H5N1 viral pathogenesis (Cameron et al., 2008).
Similar to what is observed in humans, infection of macaques with highly virulent influenza 
viruses can result in aberrant innate immune responses contributing to acute respiratory 
distress syndrome and death (Kobasa et al., 2007). Macaques infected with HPAI H5N1 
viruses exhibit stronger IFN, inflammatory, and innate immune transcriptional induction in 
lung tissue compared with seasonal virus infection (Baskin et al., 2009). Many genes which 
were highly induced in this model, including IL-1, IL-6, TNFα, and CXCL10, were 
similarly induced in ferret lungs following H5N1 virus infection (Cameron et al., 2008). 
While the majority of studies have examined host responses in respiratory tract tissues, 
upregulation of select inflammatory markers, notably hypoxia inducible factor-1α 
(HIF-1α), have been found to serve as indicators of extra-pulmonary tissue reactions during 
H5N1 virus infection in the macaque model (Tolnay et al., 2010). In addition to location, the 
timing of induction of genes related to inflammatory responses may contribute to the 
resulting severity of disease. Viruses which mount a lethal infection in macaques exhibit 
upregulation of numerous genes as early as 12 h p.i. compared with viruses which cause a 
non-lethal infection (Cilloniz et al., 2009). However, nonlethal viral pneumonia following 
H5N1 virus infection in rhesus macaques has been shown to elicit transcriptional changes in 
the lung as early as 6 h p.i., leading to the upregulation of numerous inflammatory, antiviral, 
and apoptotic genes in this tissue, mirroring that observed in humans (Shinya et al., 2012a).
5.3. Role of other host factors
Following H5N1 influenza virus infection in mammals, there is a rapid virus-mediated 
antagonism of host factors to counteract the establishment of a strong antiviral state (Hale et 
al., 2010). The interferon-induced resistance factor Mx1, known to inhibit primary 
transcription of the influenza A virus genome, is a key component of the innate immune 
system in outbred mammalian species but is not intact in standard laboratory mouse strains 
(Grimm et al., 2007). Many influenza viruses which cause severe disease in standard 
laboratory Mx1−/− mice, including HPAI H5N1 viruses, do not maintain this high virulence 
in mice carrying a wild-type Mx1 gene (Mx1+/+) (Salomon et al., 2007b; Tumpey et al., 
2007b). Compared with standard laboratory mouse strains, Mx1+/+ mice downregulate the 
expression of genes associated with hypercytokinemia and hyperchemokinemia, and 
upregulate genes associated with establishment of an antiviral state (Cilloniz et al., 2012). 
The identification of Mx1 expression to inhibit viral polymerase activity following infection, 
resulting in reduced viral replication and spread, identifies a potential mechanism for future 
antiviral drug development in humans (Grimm et al., 2007; Salomon et al., 2007b). Unlike 
mice, guinea pigs possess a functional Mx gene, which may contribute to the limited 
virulence of HPAI H5N1 viruses additionally observed in this model (Van Hoeven et al., 
2009).
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Numerous other host factors contribute to pathogen recognition and response and, with the 
use of mammalian models, have been identified to contribute to H5N1 pathogenesis. 
Activation of Toll-like receptor (TLR) signaling pathways (notably TLR3 and TLR4 via 
prestimulation of mice with TLR-specific ligands) has been shown to increase protection 
against HPAI H5N1 virus infection in mice (Shinya et al., 2011c; Wong et al., 2009). More 
specifically, the use of inactivated H5N1 virus and H5N1 viral infection of primary lung 
cultures derived from mice deficient in components of TLR4 signaling has identified roles 
for the TLR4-TRIF pathway in the development of acute lung injury and the stimulation of 
protective innate immune responses following virus infection (Imai et al., 2008; Shinya et 
al., 2012b). These studies also identified higher production of reactive oxygen species (ROS) 
in alveolar macrophages from mice treated with inactivated H5N1 but not H1N1 virus, and 
enhanced generation of oxidized phospholipids in lungs of mice infected with H5N1 virus, 
indicating that H5N1 virus infection triggers oxidative stress machinery contributing to 
severe lung disease (Imai et al., 2008). Elevated levels of autophagosomes are present in the 
lungs of humans and mice following H5N1 virus infection compared with seasonal viruses, 
and H5N1 virus infection has been linked to suppression of the mammalian target of 
rapamycin in mouse cell models, resulting in increased autophagic cell death and acute lung 
injury following virus infection. These results suggest that autophagy inhibitors may 
represent potential agents for prophylactic or therapeutic use against this virus (Ma et al., 
2011; Sun et al., 2012). It is clear that the identification of signaling pathways whose 
activation contributes to the establishment of an antiviral state against H5N1 viruses is 
urgently needed to develop novel methods to prevent and treat disease caused by influenza 
viruses.
Several studies have demonstrated that the dysregulation of host innate immune responses 
following H5N1 virus infection in mammals extends to the complement system, a major 
effector mechanism of antibody dependent and independent immunity which leads to 
optimal pathogen recognition and elimination (Daha, 2010). Mice deficient in hemolytic 
complement or complement component C3 exhibited greater mortality following H5N1 
virus challenge compared with wild-type mice, demonstrating the need for an intact 
complement pathway to mount adequate adaptive responses to H5N1 virus infection (Boon 
et al., 2009; O’Brien et al., 2011a). The dysregulation of complement proteins following 
H5N1 virus infection has been documented in mice, ferrets, and macaques, identifying 
important roles for complement in T cell priming and migration to the lung in addition to 
promoting T cell expansion during influenza virus infection (Baskin et al., 2009; Boon et al., 
2009; Cameron et al., 2008; O’Brien et al., 2011a).
Depletion of lymphocytes in H5N1 virus-infected mammals can result in multiple 
immunologic defects, contributing to greater virus replication and host range in addition to 
impairing appropriate induction of adaptive responses. As first shown in the mouse model, 
increased levels of apoptosis in H5N1 virus-infected mice leads to the depletion of 
lymphocytes in peripheral blood and tissues (Tumpey et al., 2000). Thymic involution and 
depletion of CD4–CD8 double-positive thymocytes are also detected in mice infected with 
virulent H5N1 viruses (Szretter et al., 2007; Tumpey et al., 2000). This loss of innate 
immune cells, notably macrophages and dendritic cells, in addition to the T cell depletion 
observed following H5N1 virus infection in mice, can result in an inability to mount 
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adaptive immune responses, negatively affecting host outcome (Perrone et al., 2008). Studies 
in outbred mammalian models have supported these findings. H5N1 virus-infected 
macaques exhibit a dramatic depletion of circulating CD4+ and CD8+ T cells compared to 
infection with seasonal viruses, likely due to interactions with circulating type I IFNs 
inducing vascular margination of T lymphocytes or apoptosis (Baskin et al., 2009). 
Activated dendritic cells in these animals are also depleted due to apoptosis, resulting in a 
likely disruption of cell-mediated antiviral responses and initiation of adaptive immune 
responses due to H5N1 virus infection (Baskin et al., 2009). The dysregulation of 
inflammation and cell death-related pathways observed in these macaques may be attributed 
in part to virus-induced changes in expression signatures of cellular microRNAs, resulting in 
the alteration of expression profiles of target genes associated with the inflammatory process 
(Li et al., 2011b). While it is clear that lymphocyte depletion following H5N1 virus infection 
can have a negative effect on host outcome, aberrant increases in cell populations can also 
contribute to viral pathogenesis. H5N1 virus infection has been shown to cause the increased 
selective accumulation of a particular dendritic cell subset (TNFα/inducible nitric oxide 
synthase producing dendritic cells, or tipDCs) in the lungs of mice; while ablation of this 
population did not alter the severe disease seen with this virus subtype, selectively reducing 
the accumulation of this subset resulted in increased survival (Aldridge et al., 2009). 
Collectively, these studies underscore the complex relationship between the innate and 
adaptive immune responses and how perturbation of this balance following H5N1 virus 
infection can have a detrimental effect on the host.
6. Modulation of H5N1 virus pathogenicity in the laboratory
6.1. HA protein
The influenza hemagglutinin (HA) is the major target of host protective antibodies. This 
protein undergoes continuous genetic and antigenic evolution, resulting in the emergence of 
several phylogenetically and geographically distinct clades and subclades (Abdel-Ghafar et 
al., 2008). Despite the important role of the HA in influenza virulence, numerous studies 
have shown that the surface glycoproteins by themselves are not the sole determinants of 
virus pathogenicity in mammals (Fig. 3). Reassortant viruses that possess the HA (with or 
without the neuraminidase (NA)) from a virulent H5N1 virus with all internal genes derived 
from nonlethal avian or human viruses do not typically exhibit pronounced increases in 
pathogenicity in mice or ferrets compared with the backbone wild-type strain, though 
modest strain-specific increases in virulence have been documented (Chen et al., 2007; Imai 
et al., 2010, 2012; Maines et al., 2006, 2011a; Salomon et al., 2006).
The posttranslational cleavage of HA0 into HA1 and HA2 subunits activates the membrane 
fusion potential of the HA and as such serves as a necessary step for virus infectivity 
(Steinhauer, 1999). The majority of avian influenza viruses possess a single arginine residue 
at the HA cleavage site which is sufficient for cleavage to occur by extracellular trypsin-like 
proteases that are generally limited to the respiratory tract (Böttcher et al., 2006). In contrast, 
passage of H5N1 viruses through terrestrial poultry typically results in the acquisition of 
multiple basic amino acids at the HA cleavage site, which permits HA0 cleavage by 
ubiquitously expressed intracellular proteases, including furin-like proteases, enabling 
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dissemination of virus beyond respiratory tract tissues (Steinhauer, 1999). A necessary role 
for a multibasic amino acid cleavage site in H5N1 mammalian virulence has been identified, 
as removal or replacement of this sequence with that from an avirulent avian strain results in 
reduced lethality, lower virus titers in respiratory tract tissues, restricted virus spread to 
extrapulmonary tissues, and weakened induction of host responses in vivo (Hatta et al., 
2001; Horimoto and Kawaoka, 1994; Suguitan et al., 2012). However, possession of a 
multibasic amino acid cleavage site is not sufficient for a virulent phenotype, as not all HPAI 
H5N1 viruses which contain this feature are lethal in mammals (Maines et al., 2005).
The presence a multibasic amino acid cleavage site is not the only molecular determinant 
associated with the activation of HA protein leading to membrane fusion. As membrane 
fusion and conformational changes are pH-dependent, residues in the fusion peptide pocket 
which regulate the acid stability of the HA protein can play an important role in virus 
infectivity and replication (Reed et al., 2009). Demonstrating a role for the HA fusion 
peptide pocket in mammalian virulence of H5N1 viruses, a K58I substitution in the HA2 
resulted in a decreased pH of fusion, increased HA stability, and higher virus infectivity in 
mice (Krenn et al., 2011). Additionally, the passage of avian H5N1 viruses through 
terrestrial poultry can frequently result in the acquisition of additional glycosylation sites 
proximal to the HA receptor binding site (Banks and Plowright, 2003). Glycosylation of the 
H5 HA protein has been shown to restrict the access of proteases to the cleavage site, mask 
antigenic epitopes, modulate receptor binding preference and restrict virus replication 
(Deshpande et al., 1987; Wang et al., 2010). In accordance with this, the presence of 
additional carbohydrate moities on the HA protein, in particular at position 158, has been 
shown to cause decreased virulence of H5N1 viruses in mice and ferrets compared with 
wild-type virus (Chen et al., 2007; Matsuoka et al., 2009; Wang et al., 2010).
As discussed previously, the HA mediates binding of influenza viruses to host cell 
glycoconjugates containing terminal SA residues. H5N1 avian influenza viruses typically 
exhibit preferential binding to SA linked to galactose by an α(2-3) linkage, whereas human 
influenza viruses preferentially bind to receptors that possess an α(2-6) linkage, which are 
more prevalent on human respiratory tract epithelia (Matrosovich et al., 2000; Steinhauer, 
1999). It is generally believed that, in order to cause a pandemic, currently circulating H5N1 
viruses must acquire a human receptor binding preference to achieve a transmissible 
phenotype. Mutational studies using the virulent 1918 H1N1 pandemic strain have 
demonstrated that changing the receptor binding preference of this virus (by introducing the 
amino acid changes D190E and D225G in the HA) does not abolish the lethal phenotype of 
this virus in ferrets (Tumpey et al., 2007a). However, as the severity of H5N1 disease is 
believed to be due in part to virus attachment to α(2-3) linked SA present in high 
proportions in the human lower respiratory tract, a receptor binding switch of this virus 
subtype could in turn alter the cellular tropism and virus pathogenicity in mammals. A wild-
type H5N1 virus isolated in 2003 which exhibited dual α2-3/α2-6 SA binding did not 
possess a lethal phenotype in mice or ferrets, but also was found to lack other molecular 
correlates associated with virulence in these models (Shinya et al., 2005).
The use of reverse genetics has allowed for a greater understanding of the contribution of 
receptor binding preference as it contributes to virus pathogenicity. H5N1 viruses bearing 
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mutations in the HA which conferred increased binding to α(2-6) linked SA glycans and/or 
reduced binding to some α(2-3) linked SA generally exhibited comparable to reduced 
virulence in the ferret model compared with wild-type virus (Chen et al., 2012; Maines et 
al., 2011b). Furthermore, a genetically modified H5N1 virus capable of transmission by 
respiratory droplets in the ferret model lacked the high virulent phenotype observed with 
wild-type virus unless the virus was inoculated intratracheally at a high volume and 
concentration (Herfst et al., 2012). These studies are in support of additional work which has 
revealed that alteration of the HA receptor binding pocket is capable of modulating viral 
pathogenesis. Amino acid position 222 lies within the 220 loop of the receptor binding site 
of the HA and has been proposed to contribute to viral replication efficiency and organ 
tropism, as a lysine at this position facilitated extrapulmonary virus spread in mice whereas 
a glutamic acid at this position limited virus replication and reduced binding affinity to sialic 
acids (Manz et al., 2010).
6.2. NA protein
An evolutionary balance between the HA and NA surface proteins of influenza viruses plays 
an important role in virus entry and egress from host cells (Baigent and McCauley, 2001). 
As a result, mutations within the active sites of either the HA or NA can influence the 
enzymatic activity of both surface glycoproteins. For example, adaptation of H5N1 viruses 
to terrestrial poultry results not only in the addition of increased HA glycosylation but also a 
shortening of the NA stalk. These changes can greatly affect the virulence of H5N1 viruses 
in mammals, as H5N1 viruses with a truncated NA protein exhibit enhanced virulence in 
mice compared with viruses with longer NA stalks (Matsuoka et al., 2009). Compatibility 
between the HA and NA has also been shown to contribute to the high virulence of H5N1 
viruses in the ferret model. Substitution of the NA gene of an H5N1 virus of low virulence 
in the ferret model on the backbone of a highly virulent H5N1 virus was sufficient to reduce 
peak virus titers, morbidity, and mortality following infection compared with wild-type virus 
(Maines et al., 2011a). The reciprocal constellation did not result in an increase in virulence, 
demonstrating the importance of maintaining compatibility between the HA and NA to 
achieve maximal virulence in mammals. However, substitution of the NA gene of a human 
H3N2 virus on the backbone of a highly virulent H5N1 virus reduced the lethality or 
efficient virus replication of the backbone virus in ferrets but not mice, indicating that the 
ability of NA to functionally support the activity of the H5 HA is both host- and strain-
dependent (Chen et al., 2008; Jackson et al., 2009).
Neuraminidase inhibitors (oseltamivir and zanamivir) are a critical class of antiviral drugs 
for the treatment of both human and avian influenza viruses, but the isolation of oseltamivir-
resistant H5N1 viruses from infected patients demonstrates that resistant variants can cause 
severe disease in humans (Abdel-Ghafar et al., 2008). Viruses which possess H274Y in this 
protein (conferring a resistant phenotype to this class of drug) are capable of causing severe 
and fatal disease in both the mouse and ferret models (Govorkova et al., 2010; Yen et al., 
2007a). Additional mutations in the NA which confer reduced susceptibility to oseltamivir, 
notably E119A and N294S, can also result in a lethal infection in these species, with viral 
titers and inflammation in the lungs matching or exceeding that observed during wild-type 
virus infection (Ilyushina et al., 2010). However, this effect is strain-specific, as H5N1 
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viruses bearing H274Y or N294S can also exhibit an attenuated phenotype in mice and 
ferrets (Govorkova et al., 2010; Kiso et al., 2011). These studies underscore the importance 
of studying the contribution of these mutations on virus fitness in mammals in addition to 
highlighting the need for new therapeutic agents against this virus.
6.3. Polymerase complex
The polymerase PB2, PB1, PA, and the nucleocapsid protein (NP) together form the 
ribonucleoprotein complex (RNP). This complex, which possesses RNA-dependent RNA 
polymerase activity and contains nuclear localization signals to facilitate transcription of 
viral RNA (vRNA), has known roles in both virulence and determination of host restriction 
(Naffakh et al., 2008). Demonstrating a role for the polymerase genes in H5N1 pathogenesis 
in mammalian models, reassortant viruses bearing polymerase genes from a human H3N2 
virus (RNP in ferrets, PB2, PB1, PA in mice) on the backbone of a highly virulent H5N1 
virus abolished the high virulence observed with the wild-type H5N1 virus in both species 
(Chen et al., 2008; Maines et al., 2006). Furthermore, substitution of the PB2, PB1, and PA 
from an H5N1 virus of low virulence in the ferret model on the backbone of a highly 
virulent H5N1 virus was sufficient to abolish the high pathogenicity observed with the wild-
type strain in both mice and ferrets (Maines et al., 2011a; Salomon et al., 2006). The 
reciprocal constellation generally restored the high pathogenicity phenotype in both species, 
with slight strain-specific differences observed in the ferret model. Study of the cooperative 
nature of genes within the polymerase complex has identified properties which influence the 
host range and virulence of wild-type H5N1 viruses. Adaptive mutations in the PB2 and NP 
genes which modulate binding specificity of importin-α, an adaptor protein that mediates 
nuclear transport, have been associated with avian-mammal adaptation and interspecies 
transmission of H5N1 viruses (Gabriel et al., 2008, 2011). Due to the importance of optimal 
polymerase complex activity in viral replication and virulence, identification of mutations in 
the PA and PB1 genes or PB1 and PB2 genes, which lead to modulations in polymerase 
assembly, activity, and virulence, have been proposed as a novel mechanism to attenuate 
H5N1 viruses (Li et al., 2011a; Manz et al., 2011). These studies highlight the importance 
for compatibility between the viral genes which comprise the RNP.
Critical roles have been identified for each polymerase gene in the virulence of H5N1 
viruses in mammals. The use of single gene reassortant viruses has identified that the 
presence of either the PB1, PB2, or PA gene derived from an H5N1 virus of low virulence 
on the backbone of a highly virulent H5N1 virus is sufficient to greatly reduce or abolish the 
virulence of the parental strain in ferrets (Maines et al., 2011a; Salomon et al., 2006). 
Similar studies which have created single gene reassortant viruses between human H3N2 
virus and H5N1 virus polymerase genes in mice have yielded similar results (Chen et al., 
2008). Reciprocal studies have found that the addition of either the PB2, PB1, or PA gene 
derived from a highly virulent H5N1 virus greatly increases the pathogenicity of a virus 
which is otherwise not highly pathogenic in mice or ferrets (Chen et al., 2008; Maines et al., 
2011a). The role of PB1, a protein which initiates transcription and catalyzes nucleotide 
additions during elongation, has been of particular interest as all three pandemic viruses of 
the 20th century possessed an avian PB1 gene (Kawaoka et al., 1989; Naffakh et al., 2008; 
Taubenberger et al., 2005). The substitution of a PB1 gene from a human H3N2 virus on the 
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backbone of a virulent H5N1 virus was sufficient to abrogate the lethal phenotype of the 
H5N1 virus in ferrets, and did not increase the pathogenicity of H5N1 viruses of reduced 
virulence in mice (Jackson et al., 2009; Li et al., 2010). Substitution of an avian H5N1 PB1 
gene enhanced the polymerase activity of an attenuated human virus in mammalian cells, 
with a valine at position 473 and a proline at position 598 attributed to conferring this 
phenotype (Xu et al., 2012). Furthermore, a histidine at position 436 attenuated the lethality 
of an H5N1 virus in both mice and ferrets (Hulse-Post et al., 2007). Just as balanced 
enzymatic activity between the influenza virus surface glycoproteins contributes to H5N1 
virulence in mammals, optimal compatibility between the proteins which form the RNP is 
also an important contributor to the overall pathogenesis of avian influenza virus infection.
6.4. PB2 protein
Avian H5N1–human H3N2 influenza virus reassortant studies have identified that the 
presence of a human PB2 is a major determinant for the pathogenicity of resulting viruses in 
mice (Li et al., 2010). The principle PB2 molecular determinant associated with the 
determination of host range and pathogenicity of H5N1 viruses in mammals is the amino 
acid present at position 627 (Chen et al., 2006; Hatta et al., 2001; Subbarao et al., 1993). 
Human influenza viruses typically possess a lysine at this position, whereas most avian 
viruses bear a glutamic acid, though this can vary between H5N1 virus clades (Bogs et al., 
2011). With the use of plasmid-based reverse genetics, numerous studies have investigated 
the role of this amino acid position on H5N1 pathogenesis. A single E627K mutation is 
sufficient to convert a nonlethal H5N1 virus to a lethal virus in mice, and conversely, the 
K627E substitution attenuates the highly virulent phenotype of H5N1 viruses in mice and 
ferrets (Hatta et al., 2001; Shinya et al., 2004). The presence of a lysine at this position 
confers to H5N1 viruses the ability to replicate with higher efficiency in upper and lower 
respiratory tract tissues in mice compared with viruses bearing a glutamate at this position 
(Hatta et al., 2007). This increase in virus replication is correlated with a highly activated 
inflammatory response in the lungs of mice, characterized by increased apoptosis in the 
lungs and a decrease in oxygen saturation; T-cell receptor activation is also impaired (Fornek 
et al., 2009). The E627K substitution also provides the ability for avian influenza viruses to 
replicate at 33 °C, the temperature of the human respiratory tract (Hatta et al., 2007; Massin 
et al., 2001). Furthermore, mutations in PB2 and NP genes can influence virus 
pathogenicity, as a lysine at position 357 of NP contributes to virulence in vivo when the 627 
K mutation is present (Gabriel et al., 2011; Kim et al., 2010). Collectively, these studies 
indicate that infection with an H5N1 virus bearing a lysine at position 627 can contribute to 
an inability for an infected mammal to contain the virus at the primary site of replication, 
resulting in systemic spread of virus and ultimately a lethal outcome.
While a lysine at position 627 is frequently associated with a lethal phenotype in mammals, 
it is not necessary for a virulent phenotype in mammalian hosts (Govorkova et al., 2005; 
Maines et al., 2005). This is further supported by the absence of a clear correlation between 
the amino acid present at position 627 and the clinical outcome of H5N1 human infections 
(de Jong et al., 2006). In the absence of E627K, additional mutations at other sites of PB2 
can compensate to maintain a virulent phenotype in mammals (Li et al., 2009). Infection of 
mice with an H5N1 virus bearing an asparagine at position 701 was associated with 
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systemic spread of virus and enhanced mortality compared with a virus bearing an aspartic 
acid at this position (Li et al., 2005). An asparagine at position 701 has also been shown to 
compensate for the lack of a lysine at position 627 with regard to H5N1 virus infectivity and 
transmissibility in the guinea pig model (Steel et al., 2009a). Additional amino acids in this 
protein have been associated with modulation of virus pathogenicity, including the 
substitutions T271A, the presence of which enhanced polymerase activity in mammalian 
cells, and E158G and 591K, both of which were associated with increased morbidity and 
mortality of H5 influenza viruses in mice (Bussey et al., 2010; Yamada et al., 2010; Zhou et 
al., 2011). It is clear from these studies that point mutations in the PB2 protein of H5N1 
viruses can drastically influence virus pathogenicity in mammals, warranting their close 
surveillance to better predict virus pathogenicity in mammalian models.
6.5. PB1-F2 protein
Produced by an alternate reading frame in the PB1 gene, PB1-F2 is a proapoptotic protein 
which localizes to the inner and outer membrane of host mitochondria and causes the 
destruction of alveolar macrophages (Chen et al., 2001; Coleman, 2007; Zamarin et al., 
2005). While PB1-F2 is present in all influenza virus subtypes, many viruses possess a 
truncated PB1-F2 sequence which renders the protein nonfunctional, influencing viral 
pathogenicity in mammalian species (Zell et al., 2007). In support of this, influenza virus 
PB1-F2 knockout mutants were less virulent in mice and displayed reduced viral polymerase 
activity compared with viruses bearing a full-length protein (Chen et al., 2010a; Zamarin et 
al., 2006). The H5N1 PB1-F2 has been shown to contribute to mammalian pathogenesis, as 
the presence of this protein was associated with a delay in viral clearance in mice following 
infection, allowing for prolonged viral replication and increased immunopathology in the 
lungs (Zamarin et al., 2006). PB1-F2 expression has also been associated with susceptibility 
to secondary bacterial pneumonia following infection with highly pathogenic influenza 
viruses, although the contribution of this to H5N1 pathogenesis has not been fully evaluated 
(McAuley et al., 2007).
Beyond the presence of an intact PB1-F2 protein contributing to viral pathogenicity, 
additional virulence markers have been identified for this protein. H5N1 viruses from the 
1997 outbreak bearing a serine at amino acid position 66 exhibited a high pathogenicity 
phenotype in mice compared with viruses bearing an asparagine at this position (Conenello 
et al., 2007). Presence of this 66S mutation in the H5N1 PB1-F2 led to delayed activation of 
IFN-stimulated gene expression, increased cytokine and chemokine levels, and increased 
infiltration of monocytes and neutrophils in the lungs of mice compared with 66N 
(Conenello et al., 2011). Furthermore, a N66S substitution in a HPAI H5N1 virus isolated 
from a fatal case in 2004 was associated with increased neurotropism in Mx+/+ mice 
compared with infection with wild-type virus (Schmolke et al., 2011). These studies have 
identified that N66S-induced pathogenesis is due to inhibition of early type I IFN responses 
at the level of the mitochondrial antiviral signaling protein (MAVS) and not via modulation 
of adaptive immune responses (Conenello et al., 2011; Varga et al., 2011). The C-terminus 
of PB1-F2 (which contains a mitochondrial targeting sequence) has also been shown to 
enhance the inflammatory response leading to heightened immunopathology of H5N1 
viruses in mice (McAuley et al., 2010). Collectively, this work has identified this protein as 
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an important yet strain-specific pathogenicity factor of highly pathogenic avian influenza 
viruses.
6.6. NS1 protein
The NS gene of influenza virus encodes two proteins: NS1, a multi-functional nonstructural 
RNA-binding protein that functions as an antagonist to block type I IFN-mediated host 
antiviral responses following infection, and NS2, also known as nuclear export protein 
(NEP), which is encoded by a spliced mRNA (Garcia-Sastre, 2001). During influenza virus 
infection, NS1 sequesters double-stranded RNA (dsRNA) generated during virus replication, 
inhibiting PKR activity to binding to free dsRNA, and preventing transcription of antiviral 
genes among other functions (Garcia-Sastre, 2001). To demonstrate this, infection of 
epithelial cells with NS1-deficient viruses resulted in the heightened expression of numerous 
antiviral response genes, including retinoic acid inducible gene I (RIG-I) and melanoma 
differentiation-associated gene 5 (MDA5) compared to infection with wild-type viruses 
(Guo et al., 2007; Opitz et al., 2007). Infection of mammalian models with single-gene 
reassortant viruses has further identified a contribution of the NS gene to H5N1 virus 
pathogenicity. Substitution of the NS gene of a HPAI H5N1 virus onto the backbone of a 
human H1N1 virus or reassortant H3N2 virus resulted in increased viral pathogenicity in 
mice and a strong modulation of lymphohe-matopoietic and cytokine-mediated antiviral 
responses following infection, respectively (Hyland et al., 2006; Lipatov et al., 2005). 
Furthermore, the presence of an NS gene from a human H3N2 virus on the backbone of a 
highly virulent H5N1 virus resulted in decreased virulence in mice compared with wild-type 
virus (Chen et al., 2008). However, many of the contributions of NS1 to mammalian 
virulence appear to be strain-specific, as substitution of the NS gene of an H5N1 virus of 
low virulence onto the backbone of a highly virulent H5N1 virus resulted in a partially 
attenuated phenotype in ferrets but not in mice, and substitution of the NS gene of an H5N1 
virus of high virulence onto the backbone of an H5N1 virus of low virulence did not 
increase virus pathogenicity in ferrets (Salomon et al., 2006). Furthermore, substitution of 
the NS gene of an H5N1 virus of high virulence onto the backbone of an H5N1 virus of low 
virulence was not sufficient to increase virus pathogenicity in ferrets without the concurrent 
substitution of a high virulence HA gene (Imai et al., 2010).
Several molecular correlates of virulence have been identified within the NS1 protein of 
H5N1 subtype viruses. The presence of a glutamic acid at residue 92 of the H5N1 NS1 
protein has been associated with increased pathogenicity in pigs and mice, as mice infected 
with reassortant viruses being E92D at this position exhibit reduced mortality, lower viral 
titers, and reduced levels of proin-flammatory cytokines and chemokines in lung tissue 
(Lipatov et al., 2005; Seo et al., 2002). The presence of a serine at position 42 in the NS1 
protein has also been associated with increased virulence of an H5N1 virus in mice (Jiao et 
al., 2008). Furthermore, introduction of two mutations in the cleavage and polyadenylation 
specificity factor (CPSF30) binding site of the H5N1 NS1, resulting in greater stability of 
CSPF30 binding in infected cells which leads to inhibition of IFNβ mRNA production, 
resulted in enhanced replication and virulence compared with wild-type virus in mice 
(Dankar et al., 2011; Spesock et al., 2011).
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Following viral infection, the NS1 eukaryotic translation initiation factor 4GI (eIF4GI) 
binding domain (position 81–113) is recruited to the 5 untranslated region of viral mRNA, 
resulting in preferential translation of viral proteins (de la Luna et al., 1995). The presence 
of a 5aa deletion (residues 80–84) in the NS1 protein among some H5N1 viruses conferred 
resistance to the antiviral effects of type I IFNs in vitro but infection of mice with a 
reassortant virus bearing this deletion did not result in an increase in virulence unless the 
D92E mutation was also present (Li et al., 2004; Lipatov et al., 2005; Long et al., 2008; Seo 
et al., 2002). However, additional truncation of the eIF4GI binding domain resulted in an 
attenuated phenotype in mice compared with wild-type H5N1 virus, likely associated with 
the ability of these mutant viruses to induce IFNβ following infection (Zhou et al., 2010).
Unlike seasonal human viruses, the four C-terminal resides of most H5N1 NS1 proteins bear 
a type I PDZ domain binding motif which can associate with numerous cellular targets, 
resulting in a range of activities which include the disruption of cellular tight junctions and 
modulating apoptosis in infected cells, contributing to the severity of disease (Golebiewski 
et al., 2011; Jackson et al., 2008). The presence of these avian H5N1 NS1 C-terminal 
residues was found to enhance the pathogenicity of a mouse-adapted H1N1 virus but not an 
H5N1 virus, indicating that this motif likely acts in a strain-specific and host-specific 
manner (Jackson et al., 2008; Soubies et al., 2010; Zielecki et al., 2010). Due to the 
attenuated phenotype observed in mammalian species following deletion of key regions of 
the NS1 protein, live attenuated vaccines based on truncations of this protein have been 
proposed (Steel et al., 2009b).
6.7. M1 protein
The matrix (M) gene codes for two proteins, M1 and M2; M1 has numerous roles in viral 
assembly due to its association with the RNP, while M2 modulates the pH of intracellular 
compartments which enable HA-mediated fusion of viral and endosomal membranes during 
virus entry (Rossman and Lamb, 2011). Studies using mouse-adapted influenza A and B 
viruses have identified that modifications of the M1 protein, notably in the C-terminal 
domain, are associated with adaptation and efficient virus replication in this species 
(Govorkova et al., 2000; McCullers et al., 2005). Demonstrating a role for the matrix gene in 
H5N1 viral pathogenesis, a reassortant virus bearing a human H3N2 M gene on the 
backbone of a highly virulent H5N1 virus abolished the high virulence of the parental strain 
in mice (Chen et al., 2008). Further study identified that, specifically, an aspartic acid at 
position 30 and alanine at position 215 in the M1 protein were associated with increased 
virulence of an H5N1 virus in mice (Fan et al., 2009a). As the matrix gene represents a 
proposed target for vaccine strategies, a greater understanding of the contribution of M1 and 
M2 to H5N1 pathogenesis is warranted (Steel, 2011; Tompkins et al., 2007).
7. Conclusions
While H5N1 influenza viruses are responsible for a relatively low number of human 
infections each year, the high case fatality associated with human infection and potential for 
these viruses to acquire a transmissible phenotype and cause a pandemic renders this virus 
subtype a formidable public health threat. The expanding host range and geographic spread 
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of this virus subtype further underscores the need to study this virus subtype (Munster and 
Fouchier, 2009). As discussed in this review, both viral and host factors contribute to the 
pathogenesis of H5N1 viruses in mammalian species. A greater understanding of the virus–
host interactions which confer a highly pathogenic phenotype is essential to best prepare for 
and respond to future influenza pandemics.
It is important to note that H5N1 viruses are not the only avian virus subtype associated with 
human infection and death. H7 subtype viruses have caused over 100 confirmed or presumed 
human infections, with one lethality (Belser et al., 2009a). Similar to H5N1 viruses, HPAI 
H7 viruses are capable of efficient replication and systemic spread in mice and ferrets 
(Belser et al., 2007). Furthermore, many of the molecular correlates of virulence identified 
for H5N1 viruses in mammalian species are also found for HPAI H7N7 viruses (de Wit et 
al., 2010; Munster et al., 2007). LPAI H9N2 viruses have also caused sporadic human 
infections, but do not cause severe disease in laboratory mammalian models (Lu et al., 2001; 
Peiris et al., 1999; Wan et al., 2008). Nevertheless, similar to other HPAI virus subtypes, the 
contribution of the PB2 gene and position 627 to mammalian virulence is maintained in 
H9N2 viruses (Li et al., 2012). While not typically associated with human disease, many 
other virus subtypes can productively infect mammalian species and have the capacity to 
support a highly pathogenic phenotype (Gillim-Ross et al., 2008; Veits et al., 2012).
Our understanding of the molecular basis of H5N1 virulence has improved dramatically in 
the past few years. However, the continued evolution of HPAI H5N1 viruses over the past 
decade has resulted in the emergence of numerous phylogenetic groups (WHO/OIE/FAO, 
2012); future study will be needed to determine additional potential genetic changes which 
contribute to mammalian pathogenesis. The recent discovery of a twelfth influenza virus 
protein coded by an alternate reading frame of PA, termed PA-X, has been shown to 
modulate host responses to infection; future work is needed to determine the potential role 
of this protein in H5N1 viral pathogenesis (Jagger et al., 2012). Continued study of previous 
pandemic strains may also further our ability to best assess the pandemic potential of H5N1 
and other avian influenza viruses.
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Fig. 1. 
The use of different inoculation routes to investigate H5N1 virus pathogenesis. H5N1 
viruses are capable of causing systemic and lethal disease following multiple inoculation 
routes in mammalian models. Mouse studies represented in this illustration: Belser et al. 
(2009b), Bright et al. (2003), Lipatov et al. (2009), Lu et al. (1999) and Sun et al. (2009). 
Ferret studies represented in this illustration: Belser et al. (2012), Bodewes et al. (2011), 
Gustin et al. (2011a), Lednicky et al. (2010), Lipatov et al. (2009), Maines et al. (2005) and 
Shinya et al. (2011b).
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Fig. 2. 
H5N1 pathogenesis in mammals. Virus and host features associated with H5N1 viruses 
which exhibit low or high virulence in the ferret model. Inset of lung histopathology is from 
Maines et al. (2005). Low titer generally represents ≤103 EID50/g or ml, high titer generally 
represents ≥105 EID50/g or ml (Maines et al., 2005).
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Fig. 3. 
Selected molecular determinants of H5N1 pathogenesis in vivo. Shown are selected viral 
and host components associated with changes in virulence in mammalian species.
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